Recent Quotes

My Watchlist

Indicators

Microbot Medical Inc (NQ: MBOT )

0.9431 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	0.9431
Bid (Size)	0.9250 (10)
Ask (Size)	0.9590 (1)
Prev. Close	0.9431
Today's Range	0.9431 - 0.9431
52wk Range	0.8200 - 2.350
Shares Outstanding	16,504,433
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

October 15, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

September 30, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Performance

YTD	-29.09%	-29.09%
1 Month	-7.54%	-7.54%
3 Month	-0.02%	-0.02%
6 Month	+2.51%	+2.51%
1 Year	-37.13%	-37.13%

More News

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

September 17, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

August 22, 2024

From Microbot Medical Inc.

Via GlobeNewswire

MBOT Stock Earnings: Microbot Medical Meets EPS for Q2 2024

August 14, 2024

Via InvestorPlace

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

August 13, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

August 01, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

July 18, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

July 09, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

July 08, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

July 03, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

June 20, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

June 17, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

June 04, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

June 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session

June 04, 2024

Via Benzinga

Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

June 04, 2024

Via Benzinga

Dow Dips Over 300 Points; GameStop Shares Spike Higher

June 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session

June 03, 2024

Via Benzinga

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session

June 03, 2024

Via Benzinga

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

June 03, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Crude Oil Down Over 3%; US Construction Spending Falls In May

June 03, 2024

Via Benzinga

Why Microbot Medical Stock Is Up

June 03, 2024

Via Benzinga

Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May

June 03, 2024

Via Benzinga

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

June 03, 2024

From Microbot Medical Inc.

Via GlobeNewswire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.